These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 25713300)

  • 21. Autonomic cardiovascular control in methyl-CpG-binding protein 2 (Mecp2) deficient mice.
    Bissonnette JM; Knopp SJ; Maylie J; Thong T
    Auton Neurosci; 2007 Oct; 136(1-2):82-9. PubMed ID: 17544925
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk of cardiac events in Long QT syndrome patients when taking antiseizure medications.
    Auerbach DS; Biton Y; Polonsky B; McNitt S; Gross RA; Dirksen RT; Moss AJ
    Transl Res; 2018 Jan; 191():81-92.e7. PubMed ID: 29121487
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impaired spatial memory codes in a mouse model of Rett syndrome.
    Kee SE; Mou X; Zoghbi HY; Ji D
    Elife; 2018 Jul; 7():. PubMed ID: 30028675
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular basis of ranolazine block of LQT-3 mutant sodium channels: evidence for site of action.
    Fredj S; Sampson KJ; Liu H; Kass RS
    Br J Pharmacol; 2006 May; 148(1):16-24. PubMed ID: 16520744
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insights into the molecular mechanisms of bradycardia-triggered arrhythmias in long QT-3 syndrome.
    Clancy CE; Tateyama M; Kass RS
    J Clin Invest; 2002 Nov; 110(9):1251-62. PubMed ID: 12417563
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of different beta-blockers in the treatment of long QT syndrome.
    Abu-Zeitone A; Peterson DR; Polonsky B; McNitt S; Moss AJ
    J Am Coll Cardiol; 2014 Sep; 64(13):1352-8. PubMed ID: 25257637
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Longitudinal brain MRI study in a mouse model of Rett Syndrome and the effects of choline.
    Ward BC; Agarwal S; Wang K; Berger-Sweeney J; Kolodny NH
    Neurobiol Dis; 2008 Jul; 31(1):110-9. PubMed ID: 18571096
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulation of Rho GTPases rescues brain mitochondrial dysfunction, cognitive deficits and aberrant synaptic plasticity in female mice modeling Rett syndrome.
    De Filippis B; Valenti D; Chiodi V; Ferrante A; de Bari L; Fiorentini C; Domenici MR; Ricceri L; Vacca RA; Fabbri A; Laviola G
    Eur Neuropsychopharmacol; 2015 Jun; 25(6):889-901. PubMed ID: 25890884
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of epilepsy in Rett syndrome.
    Huppke P; Köhler K; Brockmann K; Stettner GM; Gärtner J
    Eur J Paediatr Neurol; 2007 Jan; 11(1):10-6. PubMed ID: 17178248
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The inherited long QT syndrome: from ion channel to bedside.
    Vincent GM; Timothy K; Fox J; Zhang L
    Cardiol Rev; 1999; 7(1):44-55. PubMed ID: 10348966
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sympathetic ganglionectomy for treatment of long-QT-interval syndrome.
    Nalbantgil I; Moss AJ
    N Engl J Med; 1972 Mar; 286(11):607. PubMed ID: 4400545
    [No Abstract]   [Full Text] [Related]  

  • 32. Cognitive and social functions and growth factors in a mouse model of Rett syndrome.
    Schaevitz LR; Moriuchi JM; Nag N; Mellot TJ; Berger-Sweeney J
    Physiol Behav; 2010 Jun; 100(3):255-63. PubMed ID: 20045424
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Altered somatosensory barrel cortex refinement in the developing brain of Mecp2-null mice.
    Moroto M; Nishimura A; Morimoto M; Isoda K; Morita T; Yoshida M; Morioka S; Tozawa T; Hasegawa T; Chiyonobu T; Yoshimoto K; Hosoi H
    Brain Res; 2013 Nov; 1537():319-26. PubMed ID: 24060648
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serial follow-up of corrected QT interval in Rett syndrome.
    Clark BC; Kopp A; Morey W; Djukic A
    Dev Med Child Neurol; 2020 Jul; 62(7):833-836. PubMed ID: 31797351
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Deletion of protein tyrosine phosphatase, non-receptor type 4 (PTPN4) in twins with a Rett syndrome-like phenotype.
    Williamson SL; Ellaway CJ; Peters GB; Pelka GJ; Tam PP; Christodoulou J
    Eur J Hum Genet; 2015 Sep; 23(9):1171-5. PubMed ID: 25424712
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting the β-adrenergic receptor in the clinical management of congenital long QT syndrome.
    Saadeh K; Shivkumar K; Jeevaratnam K
    Ann N Y Acad Sci; 2020 Aug; 1474(1):27-46. PubMed ID: 32901453
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Disruption of MeCP2 attenuates circadian rhythm in CRISPR/Cas9-based Rett syndrome model mouse.
    Tsuchiya Y; Minami Y; Umemura Y; Watanabe H; Ono D; Nakamura W; Takahashi T; Honma S; Kondoh G; Matsuishi T; Yagita K
    Genes Cells; 2015 Dec; 20(12):992-1005. PubMed ID: 26456390
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence for abnormal early development in a mouse model of Rett syndrome.
    Santos M; Silva-Fernandes A; Oliveira P; Sousa N; Maciel P
    Genes Brain Behav; 2007 Apr; 6(3):277-86. PubMed ID: 16848781
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective preservation of MeCP2 in catecholaminergic cells is sufficient to improve the behavioral phenotype of male and female Mecp2-deficient mice.
    Lang M; Wither RG; Brotchie JM; Wu C; Zhang L; Eubanks JH
    Hum Mol Genet; 2013 Jan; 22(2):358-71. PubMed ID: 23077217
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rett syndrome treatment in mouse models: searching for effective targets and strategies.
    Ricceri L; De Filippis B; Laviola G
    Neuropharmacology; 2013 May; 68():106-15. PubMed ID: 22940001
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.